Brief: MGC Pharmaceuticals Says Malta Production Facility Received EU-GMP Certification
02/05/2023 01:55
May 2 (Reuters) - MGC Pharmaceuticals Ltd MXC.AX :
* MALTA PRODUCTION FACILITY RECEIVES EU-GOOD MANUFACTURING
PRACTICE CERTIFICATION
Source text for Eikon: ID:nASX8b3zrs
Further company coverage: MXC.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Argent BioPharma
See all newsBrief: Argent Biopharma Enters Long Term Aquiol Licensing And Supply Agreement
Brief: Argent Biopharma Secures A$11M Financing Facility To Complete Strategic Acquisition
Brief: Argent Is Growing Through M&A Projected Merged Company Value Of $100M In Ac8 Asset Acquisition
Australia's Argent BioPharma set for best day in a year on AusCann deal
Brief: Argent Biopharma To Acquire Core Operating Assets And IP Portfolio Of Auscann Group